Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Baer, Charles Wang

Premium

Thomas Baer, the founder and CEO of Mountain View, Calif.-based Arcturus, has been elected as a fellow of the American Association for the Advancement of Science. Baer, who holds more than 45 patents, was elected for his “inventive developments in advanced electro-optical technology and their effective commercial dissemination.”

Previous to joining Arcturus, which develops systems for linear amplification of DNA and other microgenomics systems, Baer served as vice president and director of research at Biometric Imaging, now a subsidiary of Becton, Dickinson. He also served as vice president and director of research for Spectra-Physics, and founder of Spectra-Physics Laser Diode Systems.

People wanted: A microarray core facility for a Los Angeles, Calif., medical research institute, is looking for a research fellow to conduct gene expression profiling and microarray data mining for cancer studies. The position requires a PhD or the equivalent in molecular biology or a related field, as well as experience in molecular biology methods such as cDNA synthesis, Northern blotting, PCR, RT-PCR, and RNA isolation. Helpful experience also includes previous work with DNA microarrays and bioinformatics, as well as experience with in vitro gene expression and TaqMan. The applicant must be a US citizen or a legal resident alien. For more information e-mail Charles Wang at [email protected]

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.